Effects of a polyphenol-rich extract blend, probiotics, and hydrolyzed fiber on quality of life and gut health markers in patients with irritable bowel syndrome—A randomized, double-blind, placebo-controlled trial
IntroductionIrritable bowel syndrome (IBS) is the most prevalent functional bowel disorder impacting around 5%−10% of the general population worldwide. The pathogenesis remains unclear, however alterations in gut-brain axis play a critical role. We aimed to investigate the therapeutic potential of a...
Saved in:
| Main Authors: | Adrianna Wierzbicka, Barbara Khaidakov, Oliwia Zakerska-Banaszak, Paulina Andrzejewska, Alina Baturo, Paulina Kowalczyk, Krzysztof Lemke, Agnieszka Dobrowolska, Marzena Skrzypczak-Zielinska, Dorota Mankowska-Wierzbicka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1603011/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?
by: Marcin Gabryel, et al.
Published: (2025-04-01) -
Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?
by: Marcin Gabryel, et al.
Published: (2025-03-01) -
Mechanism of action, efficacy and adverse events of selected drugs used to treat irritable bowel syndrome (IBS): A Literature Review
by: Mikołaj Łabuda, et al.
Published: (2025-05-01) -
The Role of Non-pharmacological Treatments of Irritable Bowel Syndrome: A Literature Review
by: Oliwia Wiktoria Mentel, et al.
Published: (2025-05-01) -
Diagnosis and Treatment of the Irritable Bowel Syndrome
by: H.R. Schneider
Published: (2005-05-01)